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BACKGROUND: Moringa stenopetala is used as nourishments, 
and treatment of various diseases. However, there is no much 
information on its safety. Hence, this study aimed to investigate the 
chronic administration of aqueous leaves extract of the plant.  
MATERIALS AND METHODS: Twenty-four rats were divided 
into: a control group administered with distilled water and three 
experimental groups, respectively, administered with the extract at 
doses of 500, 1000, and 2000 mg/kg orally for six months were 
investigated. Various hematological and biochemical parameters 
followed by histopathological analysis were evaluated. 
RESULTS: Treatment with the extract did not significantly affect 
most of the hematological parameters.  However, there were a 
significant decrease of MCH at doses of 1000 mg/kg and 2000 
mg/kg in male rats and increase of MCV at all doses in female rats. 
Levels of ALP at 2000 mg/kg and those of AST and ALT at 1000 
and 2000 mg/kg were significantly increased in male rats. 
Furthermore, significant decrease in urea and increase in 
creatinine levels at the dose of 2000 mg/kg occurred in female rats. 
Mild histopathological changes were also observed in the liver of 
male rats and kidney of female rats treated with the extract, 
respectively at doses of 1000 and 2000 mg/kg, and 2000 mg/kg. 
CONCLUSION: Findings from the present study suggest that 
prolonged administration of extract of Moringa stenopetala at 
therapeutic doses is safe, but shows sign of mild toxicity as dose 
increases, with differential effect on male verses female rats. 
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Plants have traditionally been used for treatment 
and prevention of human and animal diseases. The 
major limitation of traditional medicine is, 
however, that there are no many records and 
information regarding their safety and toxicity.  
One of such plant species widely used is 
Moringa stenopetala, which belongs to the family 
Moringaceae. It is a branched tree with 
multipennate leaves that grows 6 to 10 m tall (1) at 
an altitude ranging between 1000 and 1800 m 
above sea level. The plant is endemic to East 
Africa, mainly found in Northern Kenya and 
southern part of Ethiopia (2,3). It grows abundantly 
in southwest part of Ethiopia where the leaves, 
which have high nutritional as well as medicinal 
value, are eaten as vegetable (1).  
Moringa species have been used to combat 
malnutrition, especially among infants and nursing 
mothers. Leaves can be eaten fresh, cooked, or 
stored as dried powder for many months without 
refrigeration and loss of nutritional value. 
Medicinally, almost all parts of this plant have 
been used for treating various ailments (4). 
Furthermore, its leaves act as a good source of 
natural antioxidant due to the presence of various 
types of antioxidant compounds (5). 
Laboratory based studies on different animal 
models have also suggested for medicinal and 
nutritional values of the plant. A significant drop in 
mean arterial blood pressure was reported 
following administration of M. stenopetala in 
guinea pigs (6). Furthermore, leaf extract of M. 
stenopetala were reported by several authors to 
increase body weight and reduce serum glucose 
and cholesterol levels in mice and rats (7-9). 
Because of such diverse values of M. stenopetala, 
currently, there is an increasing promotion and 
utilizations of the plant for various purposes. 
However, this may call for adequate investigation 
and proper documentation of its safety and toxicity. 
On the contrary, there are only limited studies that 
investigated the safety and toxicity of M. 
stenopetala aqueous leaf extract as most of the 
studies conducted so far are either nutritional 
analyses or efficacy tests in laboratory animals. 
Furthermore, the studies which addressed safety of 
the plant are related to acute and/or sub-chronic 
investigation, and so far, there is no study carried 
out on chronic toxicity of M. stenopetala on blood 
parameters and histopathology of liver and kidney. 
Such a chronic study, which assesses the safety of 
the plant may be needed as it is normally consumed 
for a prolonged period of time for nutritional, 
therapeutic as well as preventive purposes. The 
present study is, therefore, aimed to investigate if 
there is any effect on blood parameters as well as 
histopathology of liver and kidney following 
administration of the extract for six months in 
Wistar rats. 
 
MATERIALS AND METHODS 
 
The study was conducted at Traditional and 
Modern Medicine Research Directorate of 
Ethiopian Public Health Institute and Department 
of Anatomy, College of Health Sciences, Addis 
Ababa University. 
Collection and extraction of plant materials: 
Fresh leaves of M. stenopetala were collected from 
Arba Minch, 502 km southwest from Addis Ababa. 
The leaves were identified and authenticated by a 
taxonomist, and a voucher number MS-01-2016 
was deposited in the herbarium. Fresh leaves were 
cleaned, dried under shade at room temperature, 
and ground by manual crusher (10). The powdered 
leaves were macerated with distilled water for 4hrs 
with intermittent agitation by orbital shaker. The 
supernatant was separated from the un-dissolved 
portion, and was filtered with 0.1 mm2 mesh gauze 
and whatman filter paper. The filtrate was freeze-
dried at low temperature (-46oC -51oC) and low 
pressure (133x10-3mbr) to form crude extract and 
was kept in desiccators at room temperature until 
used (10).  
Selection and preparation of experimental 
animals: Both sexes of adult Wistar rats (8-12 
weeks old) obtained from Ethiopian Public Health 
Institute were used for the study. Females were 
nulliparous and non-pregnant.  Rats were randomly 
grouped into experimental and control groups, and 
were kept under standard conditions (temperature 
of 22°C (± 3°C), relative humidity of 50-60%, with 
12h light / 12h dark cycle) (11). For feeding, 
conventional rodent laboratory diets were used 
with water Ad libitum.  
Toxicity studies on experimental animals were 
carried out in compliance with general guidelines 
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on methodologies on research and evaluation of 
traditional medicine promulgated by WHO (12). 
The experimental design involving the mice for the 
study was also as per the guidelines for carrying 
research on animals (13).  
Method of extract administration: The extract 
and distilled water were given orally using 
intragastric catheter. Following a period of fasting, 
the animals were weighed weekly, and the dose 
was calculated according to the body weight, and 
administered each day (14).  
Chronic toxicity study: The study was carried out 
using 24 rats randomly assigned into four groups: 
one control and three experimental groups (groups 
I-III), each containing 6 rats (three males and three 
females). Rats in groups I, II and III received the 
extract of M. stenopetala at doses of 500, 1000, and 
2000 mg/kg body weight, respectively, daily for six 
months. 
Cage side observation: Treated rats were observed 
daily for any general sign of abnormalities during 
the whole study period. 
Body weight measurement: Body weights of all 
animals were recorded using digital electronic 
balance sensitive to 0.001 gm (Precisa 125A, 
Switzerland) before the first oral administration, 
and then weekly until the last day of 
administration. 
Blood samples collection: At the end of the 
experiment, animals were made to fast overnight, 
and sacrificed by cervical dislocation. Blood 
samples were then collected into sterile tube by 
cardiac puncture. Parts of the blood samples were 
put in separate test tubes with and without EDTA. 
Hematological parameters  including white 
blood cells (WBCs) and its differentials, red blood 
cells (RBCs), hemoglobin (HGB), hematocrit 
(HCT), mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), mean  corpuscular 
hemoglobin concentration (MCHC) and platelets 
were analyzed immediately from the blood samples 
collected with EDTA using Automated 
Hematological Analyzer (SYSMEX RX 21, Japan). 
For biochemical analysis, blood samples collected 
without EDTA were allowed to stand for 2 hrs for 
complete clotting and centrifuged at 5000 rpm for 
10 minutes using a bench top centrifuge (HUMAN-
GmbH, Germany). Serum from each sample was 
withdrawn through micropipette and transferred 
into other clean vial tubes which were kept at -20oC 
until analysis. Subsequently, concentrations of 
ALP, ALT, AST, total Bilirubin, Urea and 
Creatinine were determined using Clinical 
Chemistry Analyzer, Italy. 
Organs weight measurements and tissue 
processing: Liver and kidneys were dissected and 
weighed with precision electronic digital balance. 
Sample tissues from liver and left kidney were 
collected randomly and fixed in 10% buffered 
formalin. These were dehydrated and cleared in 
ascending graded series of ethanol and xylene, 
infiltrated with molten paraffin wax and embedded 
in paraffin blocks. Tissue sections were cut at 5 µm 
thickness and fixed onto clean frosted slide glasses 
and were stained with hematoxylin and eosin 
(H&E). Finally, the prepared slides were examined 
under Binocular compound light microscope for 
any possible histopathological findings and were 
photographed under X400 total magnification 
using Photomicrograph (Leica ICC50, China). 
Data processing and analysis: All data obtained 
from the experiments were entered and analyzed 
statistically on SPSS 21 version software and 
presented as mean ± standard error of the mean 
(SEM). The difference between treatment and 
control groups were compared using one-way 
analysis of variance (ANOVA). This was followed 
by analysis with Dunnett’s post hoc test which 
compares the means from several experimental 
groups against that of a control. Differences 
between the various groups were considered 




No sign of toxicity was observed in rats treated 
with the extract, except for those which received 
the extract at doses of 2000 mg/kg body weight 
which showed low locomotion, weakness, 
dizziness, shivering and piloerection during the 
first and second weeks of administration in both 
sexes. Moreover, there was no morbidity and death 
throughout the study period. 
There were progressive body weight gains in all 
groups of rats of both sexes over the whole period 
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of the experiment.  However, there were 
transitional significant body weight decrements 
during  1st and 2nd weeks (for the male) and 1st - 3rd 
weeks (for the female, Figure 1) rats treated  with 
the extract at dose of 2000mg/kg. 
No significant difference was observed in the 
pattern of body weight gain among the different 





Figure 1: Mean body weight (gram) of female rats administered with 500, 1000 and 2000mg/kg of the 
extract during the consecutive 24 weeks of measurement compared to the controls 
 
Effect of M. stenopetala aqueous leaves extract 
on hematological parameters: The effect of 24 
weeks oral administration of M. stenopetala on  
hematological parameters of the rats is illustrated 
in Table 1. Chronic administration of the extracts 
did not significantly affect the large majorities of 
the hematological parameters, except for the MCH  
and MCV. There was a significant decrement of  in 
MCH in male rats at doses of 1000 mg/kg and 2000 
mg/kg as compared to their control counterparts. In 
addition, the extract induced significant elevation 
MCV of female rats at all doses. 
Effect M. stenopetala aqueous leaves extract on 
biochemical parameters: Effects of chronic oral 
treatment with aqueous leaves extract of M. 
stenopetala on serum biochemical parameters of 
rats are shown in Table 2. Most of the biochemical 
markers were not affected in the extract treated rats 
as compared to the controls. However, in the male 
rats treated with the extract, significant increases 
were observed in the ALP at dose of 2000 mg/kg, 
and AST and ALT at doses of 1000 and 2000 
mg/kg.   Furthermore, female rats administered 
with the extract at the dose of 2000 mg/kg showed 
significant decrement and increment in urea and 
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Table 1: Effects of chronic administration of 500mg/kg, 1000mg/kg and 2000mg/kg aqueous leaf extract of M. stenopetala on hematological parameters in male (M) 
and female (F) rats as compared to the controls 
 
Hematological 
parameters 500mg/kg 1000mg/kg 2000mg/kg Control 
  M F M F M F M F 
WBC(x 103/µL) 8.7±3.14(.890) 5.10±1.36(.967) 6.3±0.67(.992) 8.49±0.86(.110) 6.3±1.01(.991) 4.18±1.43(.996) 6.99±0.50 4.48±1.11 
NEUT(x 103/µL) 1.09±0.18(.558) 0.40±0.08(.339) 1.14±0.26(.445) 0.84±0.12(.965) 0.96±0.03(.850) 0.71±0.38(.813) 0.78±0.07 0.98±0.35 
LYMPH(x 
103/µL) 6.96±2.62(.930) 4.48±1.29(.576) 4.41±0.79(.919) 6.05±0.92(.131) 4.89±0.89(.977) 3.09±1.05(.999) 5.72±0.61 5.72±0.61 
MONO(x 
103/µL) 0.57±0.24(.709) 0.23±0.03(.705) 0.60±0.08(.605) 0.60±0.29(.381) 0.38±0.11(.999) 0.27±0.05(.867) 0.35±0.04 0.37±0.13 
EO(x 103/µL) 0.17±0.04(.792) 0.12±0.01(.781) 0.15±0.05(.911) 0.19±0.02(.541) 0.03±0.01(.614) 0.09±0.04(.567) 0.11±0.61 0.18±0.10 
BASO(x 103/µL) 0.05±0.01(.898) 0.06±0.01(.732) 0.03±0.01(.952) 0.01±0.06(.299) 0.04±0.03(1.000) 0.02±0.003(.998) 0.04±0.01 0.02±0.01 
RBC(x 106/ µL) 10.01±0.57(0.603) 8.03±0.33(0.955) 9.09±0.88(1.000) 8.73±0.35(1.000) 10.03±0.22(.613) 7.21±1.62(.685) 9.07±0.17 8.66±1.38 
HGB(g/dl) 18.5±0.85(.819) 15.7±0.72(.928) 16.23±1.78(.898) 16.53±0.48(.997) 18.4±0.42(.851) 15.67±0.81(.918) 17.23±0.37 16.33±1.41 
HCT (%) 57.57±2.92(.428) 47.47±2.24(.989) 50.27±4.21(.989) 52.23±2.13(.754) 56.23±1.45(.613) 41.47±8.62(.922) 51.43±0.95 45.5±6.77 
MCV(fL) 57.33±0.54(.945) 59.10±0.79(.010)* 55.47±1.39(.669) 59.77±1.13(.006)* 56.03±0.44(.917) 58.20±1.60(.023)* 56.73±0.03 52.77±0.74 
MCH(pg) 18.47±0.23(.259) 19.53±0.27(1.000) 17.83±0.27(.010)* 18.97±0.20(.999) 17.89±0.07(.011)* 24.33±5.79(.562) 19±0.10 19.47±1.84 
MCHC(g/dL) 32.17±0.39(.479) 33.07±0.07(.889) 32.13±1.17(.460) 31.77±0.52(.779) 32.73±0.15(.823) 41.3±8.55(.821) 33.5±0.20 36.77±2.89 
PLC(x 103/µL) 339.67±229.7(.553) 120±31.34(.703) 351.67±208.9(.580) 590±113.66(.125) 720.3±93.2(.996) 256±139.4(1.000) 669.3±110.1 254.67±103.89 
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500mg/kg 1000mg/kg 2000mg/kg Control 
 M F M F M F M F 
ALP (IU/L) 109.33±8.65(.057) 84±22.05(.538) 109.67±16.76(.056) 79.33±6.64(.475) 119.67±21.67(.030)* 144±49.52(.989) 44.33±16.17 133±24.7 
ALT (IU/L) 122.47±36.46(.187) 175±54.17(.980) 149.27±33.10(.03* 96.33±14.78(.367) 136.07±42.74(.042)* 93.43±12.41(.337) 88.73±14.56 161.73±23.16 
AST (IU/L) 274.67±97.95(.157) 712.2±204.09(.438) 521±57.27(.032)* 396.53±129.72(.990) 316.03±103.60(.048)* 274.6±109.2(.733) 196.9±48.54 444.57±90.97 
Urea  (g/dl) 46.5±1.21(.879) 40.43±2.71(.075) 49.67±2.48(.303) 39.87±3.58(.062) 38.67±0.45(.193) 38.9±1.99(.044)* 44.67±3.30 51.53±3.49 
Creatinine 
(mg/dl) 
0.33±0.05(.668) 0.19±0.02(.997) 0.24±0.03(.787) 0.26±0.03(.397) 0.28±0.01(.998) 0.34±0.02(0.023)* 0.28±0.03 0.2±0.05 
Bilirubin 
(mg/dl) 
4.59±0.14(.994) 4.56±0.52(.887) 4.09±0.15(.184) 4.29±0.56(.999) 4.53±0.03(.810) 4.53±0.38(.922) 4.79±0.45 4.34±0.120 
Data are expressed as mean± SEM, N=3. The figures under brackets indicate the P-values, N= Number of rats per group;*= significant (P<0.05). 
 
 
Effect of M. stenopetala aqueous leaves extract on histology of the liver: 
Histological examination of liver sections of male rats treated with the extract 
at a dose of 500mg/kg body weight and female rats treated at all doses had 
normal architecture similar to the controls (Figure 2A, 2B). However, male 
rats treated with the extract at doses of 1000 mg/kg (Figure 2C, 2D) and 2000 
mg/kg (Figure 2E, 2F) showed signs of bile retention which suggested for 
induction of cholestasis (biliary stasis). These were observed as yellowish 
discoloring of hepatocytes and deposits in the bile canaliculi between the 
individual hepatocytes. Moreover, around the central veins and portal triads, 
there were mononuclear leukocytic cells infiltration (Figure 2E, 2F), 
congestion of sinusoids, cytoplasmic vacuolization and hydropic changes 
(Figure 1E, 1F), revealing mild hepatotoxicity. 
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Figure 2: Photomicrographs H and E stained sections of liver of male rats treated with the aqueous leaves extract of 
M. stenopetala with 1000 mg/kg (C & D) and 2000 mg/kg (E & F) as compared to the controls (A&B). Note: 
Cytoplasmic vacuolization of hepatocytes (CVH) and mononuclear leukocytic infiltrations (I) at 1000 and 2000 mg/kg; 
CV= Central vein, PV= Portal vein; all slides were at X400 
 
Effect of M. stenopetala aqueous leaves extract 
on histology of the kidney: Histological 
evaluation of kidney sections of treated rats 
showed some histopathological changes only 
in the female rats treated with the extract at a 
dose of 2000 mg/kg. These were observed as 
minor tubulointerstitial leukocytic infiltrations in 
some areas of cortex and medulla. In addition, 
widening of the urinary space and congestion of 
glomeruli in some of the renal corpuscles were 
apparent. On the other hand, no change was 
observed in the  female rats treated with the 
extract at doses of 500 and 1000 mg/kg, as well as 
male rats treated at all doses as compared to the 
controls (Figure 3). 
 
 
Figure 3: Photomicrographs H and E stained sections of kidney of female rats treated with the aqueous leaves extract 
of M. stenopetala with 2000 mg/kg (C and D) as compared to the controls (A&B). Note: Widened urinary space and 
minor tubulointerstitial infiltrations (I) G= Glomerulus, PCT= proximal convoluted tubule, DCT= distal convoluted 
tubule, OMR= outer medullary region and IMR= inner medullary region; all slides were at 400X. 
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The results of 24 weeks chronic treatment of the 
aqueous leaves extract of M. stenopetala showed 
that the extract was well tolerated by all rats. The 
mild sign of toxicity observed in rats treated with 
the extract at the dose of 2000 mg/kg body weight 
may be due to a transient nervous tissue problem 
caused by its high dose, but later tolerated.  
The extract did not adversely affect food 
intake in both sexes of the rats at all doses, and had 
no harmful effect on body growth patterns. The 
transitional body weight decrement observed at the 
dose of 2000 mg/kg body weight during the 2nd and 
3rd weeks   might be due to physiological variation 
in food intake and metabolism. During the later 
weeks, there were progressive body weight gains in 
all groups of rats of both sexes over the whole 
period of the experiment. This is in line with 
Ghebressilase et al. (7) who reported a progressive 
non-significant body weight increment with no 
significant changes between male and female rats 
that received 600, 750, 900 and 1500 mg/kg of M. 
stenopetala extract for 6 weeks. 
Evaluation of changes in organ weight 
between experimental and control animals in 
toxicological studies is an important indicator of 
toxicity (15). In the present study, there was no 
significant change in both liver and kidney weight 
in the animals that received the extract at all doses 
when compared to the controls. This finding is 
again in line with the previous subchronic study of 
Ghebressilase et al. (7) and suggest for non-toxic 
effect of the extract on the organs studied to be 
manifested by weight change. 
Investigations on blood could serve as a 
diagnostic index of pathological, toxicological and 
physiological status of animals. Blood profile 
usually provides important information on the 
response of the body to injury or lesion, 
deprivation and stress (16). Therefore, it is one of 
the most sensitive targets for toxic compounds 
(17). In this study, hematological parameters were 
evaluated to obtain any toxicity related information 
that may not be detected by gross examinations and 
assessment of organs and body weight.  
In the present study, administration of the extract at 
all studied doses did not cause significant changes 
in the total red blood cells count, HGB, HCT and 
MCVC in both sexes, although there was a 
significant decrement of MCH in male rats that 
received 1000 and 2000 mg/kg body weight. In 
addition, there was increment in the MCV values in 
female rats treated with the extract at all the three 
doses. This is in agreement with the findings of 
Adedapo et al. (18) which showed increased MCV 
and decreased MCH in rats that received 1600 and 
2000 mg/kg body weight for three weeks. The 
observed changes in the values of MCV and MCH 
might be attributed to the defect in nuclear 
maturation, as seen in megaloblastic anemia due to 
foliate or B12 deficiency, resulting in large oval 
erythrocytes (19,20). This may indicate that 
exposure to high dose of the extract for a longer 
period of time may somehow affect the intrinsic 
factors in the stomach and reduce the absorption of 
vitamin B12. 
In the present study, unlike in the female rats, 
significant increments were observed in the male 
rats treated with the extract in the levels of ALP at 
2000 mg/kg body weight dose as well as AST and 
ALT at 1000 and 2000 mg/kg body weight doses as 
compared to the controls. These observations are in 
line with those of other previous acute and 
subchronic studies of Adedapo et al. (18), Ajibade 
et al. (21) and Geleta et al. (22). Such findings 
might suggest that the extract has mild hepatotoxic 
effect in male rats. Indeed, histopathological 
findings of male rats in this study also suggest for a 
mild sign of hepatotoxicity in the rats treated at the 
higher doses. This may show that male rats are 
sensitive while female rats are resistant to the 
hepatoxic effect of phytochemicals present in M. 
stenopetala, resulting from the absence of isoform 
of cytochrome P450 involved in the bio-activation 
of alkaloid in female rats as previously suggested 
(23). 
Chronic treatment with the extract did not 
significantly affect urea and creatinine levels in 
male rats at all doses and 500 and 1000 mg/kg in 
female rats, while at dose of 2000 mg/kg, it 
significantly decreased urea and increased 
creatinine levels in female rats. The occurrence of 
significantly decreased urea and increased 
creatinine levels only in the female rats treated with 
the extract at 2000 mg/kg dose is interesting, but 
may suggest for the presence of mild 
nephrotoxicity in female rats. In line with this, 
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previously, it was suggested that female rats are 
often more sensitive to nephrotoxic compounds 
than males (11,24).  
Histological examination of liver sections of 
male rats treated with the extract of M. stenopetala 
revealed sign of mild toxicity at the higher doses, 
while at the lower dose, the normal architecture of 
the liver was not disturbed. In the male rats treated 
with 1000 and 2000 mg/kg body weight, there was 
intrahepatic and extra hepatic bile retention. 
Moreover, around the central veins and portal 
triads, there were some mononuclear leukocytic 
cells infiltration, congestion of sinusoids, 
cytoplasmic vacuolization’s of hepatocytes, and 
hydropic changes. These findings are comparable 
to that of a previous acute study by Ajibade et al. 
(21) where oral administration of a related plant, 
M. olifera  at 800 and 1600 mg/kg body weight 
induced portal cellular infiltration,  periportal  
congestion  and  hydropic  degeneration  of  
hepatocytes  in  the  liver. 
In the present study, histological evaluation 
of sections of the kidneys from rats treated with the 
extract did not show any sign of toxicity, except in 
those female rats treated at the highest dose. In the 
female rats which received the extract at the dose 
of 2000 mg/kg, there were minor tubulointerstitial 
leukocytic infiltration, wider urinary space and 
congested glomeruli in some areas of both cortex 
and medulla of the kidney sections. These findings 
are in line with a study by Ajibade et al. (21) where 
cortical congestion and interstitial hemorrhages in 
the kidneys of rats following treatment of M. 
olifera at doses of 600, 900 and 2000 mg/kg body 
weight were reported. The histological changes 
observed in the present study may also be related 
with the observed changes in the values of urea and 
creatinine at dose of 2000 mg/kg body weight in 
the female rats, and may be indicative of mild 
nephrotoxicity.  
In conclusion, the findings from the present 
study suggest that prolonged administration of the 
aqueous leaves extract of M. stenopetala in rats at 
lower doses of administration is safe. However, at a 
higher dose, it might show mild toxicity with 
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